"When the brain is working at picoTesla, why are we using a Tesla-level field to fix it?"
— Shyam Sunder, Founder & Product Lead
That question took 20 years and 600 research papers to answer. Here's what we found.
It doesn't start when you get into bed. It starts when you wake up.
The brain stays too "fast." High beta waves (alert, stressed) dominate. Low alpha (calm) means the natural sleep transition never builds during waking hours.
Trouble shifting from wake to sleep (N1 stage). The brain is still "on." The RAS — the reticular activating system — keeps firing. Sleep onset is delayed or fragmented.
Tired body. Active mind. Not a willpower problem. Not a bad routine. A chronically overactivated nervous system — driven by digital overload, stress, and a world the brain wasn't designed for.
"Existing solutions treat sleep at night. The problem starts during the day."
Variable Complex Magnetic Fields. Patented architecture. A never-repeating signal at ultra-low intensity — operating where the brain actually lives.
An ultra-weak variable magnetic field is emitted continuously from the cervical neckband. Painless. Invisible. No contact, no electrodes, no sensation. Operating at <1 μTesla — weaker than ambient EMF and your phone's magnetic field. Well below ICNIRP safety limits.
The signal reaches the Reticular Activating System (RAS) — the brain's "stay awake" switch — and gently dials it down during the day. The RAS is the gatekeeper of consciousness. In insomnia, it stays overactive. VCMF™ interrupts that pattern without suppressing it.
Alpha waves (calm, relaxed focus) strengthen during the day. Beta — the alert state — is maintained so you can function normally. The 8–30 Hz variable pattern means the brain cannot adapt and tune it out. Every session is neurologically novel.
Amygdala activity drops. The anxiety-insomnia spiral — where fear of sleeplessness creates more sleeplessness — is interrupted at its source. Theta waves are deliberately not modulated: daytime creativity, memory consolidation, and productivity are fully preserved.
You arrive at bedtime already neurologically ready. Natural onset. Deep rest. No sedation, no chemical dependency, no morning fog. Just sleep the way it was supposed to work.
Unlike TMS and clinical neuromodulation ($6K–$12K per course), VCMF™ operates at ultra-low intensity — designed for daily wearable use, not clinical one-off sessions. The mechanism is analogous but the delivery is consumer-grade: portable, affordable, daily.
Mechanisms hypothesized and under active clinical investigation. For investigational use only. Not intended to diagnose, treat, cure, or prevent any disease.
One published, peer-reviewed, placebo-controlled clinical trial. Here's what it found.
Major adverse events across the entire study
18,000+ hours of cumulative use. Zero serious safety signals. Weaker than ambient EMF.We have one published RCT. It validates the mechanism. We are now building the real-world evidence base through early adopter usage — and that data is what powers the next phase of clinical validation.
We believe in honest science. The trial is real, the numbers are real, and the limitations are real. Read it yourself: → View on PubMed: PMC10307909
Muse EEG headband · Mind Monitor app · Evolv28 neuroband · Single session
A user wore a consumer EEG device simultaneously with Evolv28 and tracked her brainwave activity before and after activation. This is what the data showed.
Alpha waves are the brain's calm signal — relaxed alertness, readiness to transition toward sleep. After Evolv28 activation, alpha rose from ~0.18 to 0.25+ in the session measured.
Beta is the "busy mind" frequency — stress, rumination, arousal. A modest reduction without full suppression. Focus is preserved. Edge stays sharp. The overactivation quiets.
Theta waves govern creativity, memory consolidation, and daytime cognitive flow. They were deliberately left out of the VCMF™ signal profile. Daytime productivity is fully preserved.
N=1 internal pilot. EEG data from real user session. For investigational use only. Results vary between individuals.
VCMF™ wasn't discovered in a lab sprint. It was the conclusion of decades of clinical observation, research, and iteration.
MedTech innovator with 20+ years in clinical translation — from research into scalable device. Spent over a decade reviewing 600+ research papers before arriving at the picoTesla question. Designed, prototyped, and deployed the VCMF™ architecture from the ground up.
"The brain is exquisitely sensitive. We kept building hammers when it needed a feather."
Category creation specialist with a track record of building markets from scratch. Led commercial growth for the $7B+ CGM category. Managed $125M+ P&L across global operations. 16+ years of B2B and clinical-scale commercial architecture across healthcare and life sciences.
"852 million people are not sleeping. The market is not the problem. The solution is."
Fortune 100 growth advisor. 20+ years of commercial architecture across digital transformation, innovation strategy, and scaling emerging-technology companies from early traction to institutional adoption.
Digital health pioneer with deep expertise at the intersection of technology and healthcare. Early builder of the digital health category — bringing clinical credibility and distribution strategy to emerging med-tech.
20+ years in distribution, content, and platform growth across media and entertainment. Brings consumer acquisition playbooks and partnership architecture to the Evolv28 commercial launch.
Leading PR and communications strategy for the Evolv28 launch. SparksCG brings category-defining communications experience — shaping narratives for breakthrough health and wellness companies at the moment they enter the public conversation. SaraJane ensures the Evolv28 story reaches the right journalists, clinicians, and consumers with clarity and credibility.
Join the waitlist and we'll be in touch when yours is.
Questions? Email us at hello@evolv28.com